Brief: Heartbeam announces FDA submission of Heartbeam Aimi™ product
16/08/2022 13:45
Aug 16 (Reuters) - Heartbeam Inc BEAT.O :
* HEARTBEAM ANNOUNCES FDA SUBMISSION OF HEARTBEAM AIMI™
PRODUCT
Source text for Eikon: ID:nBw5g9k84a
Further company coverage: BEAT.O
Recent news on HeartBeam
See all newsBrief: Heartbeam Receives FDA Breakthrough Device Designation For Heart Attack Assessment
Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
Brief: Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock
HeartBeam, Inc. reports results for the quarter ended June 30 - Earnings Summary
HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance